[Patients exert pressure. Is drug approval to be accelerated?].
Rautenstrauch
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval; D004345:Drug Industry; D005060:Europe; D005260:Female; D006801:Humans; D017387:Investigational New Drug Application; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008875:Middle Aged; D010361:Patients; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D000970:Antineoplastic Agents